Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Disease Progression × carotuximab × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 3 Glioma 2 Oligodendroglioma 1 Gliosarcoma 1 Disease Progression 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

vandetanib 2 Bevacizumab 2 Anthropogenic Effects 2 enzastaurin 1 carotuximab 1 Temozolomide 1 Tamoxifen 1 Steroids 1 Irinotecan 1 Carboplatin 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01778530 2015-10-07

TRC105 for Recurrent Glioblastoma

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated

2 enrolled 9 charts

Glioblastoma, Glioma, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡